Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Medclair receives a new order worth approximately 12 MSEK in the UK

MCLRSelskabsmeddelelse20.08.2026, 08.32
Download udgivelse

Medclair has received a new order from a leading player in the recycling sector. The order value amounts to approximately 12 MSEK and pertains to the UK market. Parts of the order include an installation in Scotland, which means that Medclair is establishing itself in a new geographical market.

Through the new order, Medclair continues to gain ground in the recycling sector, a segment where the company has built a stable and growing customer base in several European countries in recent years. With the installation in Scotland, Medclair's technology for the recycling sector is now in place in England, Scotland, Ireland, Belgium, France, Denmark, and Sweden.

The order confirms the demand Medclair sees in the recycling segment and strengthens the company's position as an established provider of solutions for nitrous oxide destruction for players in waste management and recycling in the UK and the rest of Europe.

"Taking on Scotland as a new market is clear proof that our technology for safe and sustainable nitrous oxide management is in broad demand within the recycling sector, both in the UK and in the rest of Europe. Recycling has in a short time developed into one of our most important growth areas, and together with dental and healthcare, we now have three stable business areas – industry, dental, and healthcare – to rely on in our continued expansion," says Jonas Lundh, CEO of Medclair.

Medclair's three business areas – industry, dental, and healthcare – provide the company with a broader revenue base and reduce its dependence on individual segments or markets. The recycling sector, which is part of the industry business area, has grown over the past year to become a significant part of the order intake and contributes to spreading the company's geographical and commercial risk.

Jonas Lundh
CEO
Medclair AB

For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com

About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.

The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.

This information is information that Medclair is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-20 08:32 CEST.

Attachments
Medclair receives a new order worth approximately 12 MSEK in the UK